Back to search results

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Metastatic Uveal Melanoma · Cutaneous Melanoma · Colorectal Cancer · Other Solid Tumors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • UCLA Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Bartosz Chmielowski, MD) · BChmielowski@mednet.ucla.edu
    Contact: Principal Investigator (Bartosz Chmielowski, MD)

  • San Francisco Oncology Associates, San Francisco, California, United States

  • SCRI - Denver, Denver, Colorado, United States

    Contact: Study coordinator (Ryan Weight, MD) · ryan.weight@theskincancerinstitute.com
    Contact: Principal Investigator (Ryan Weight, MD)

  • University of Iowa, Iowa City, Iowa, United States

  • Cancer Hematology Centers Western Michigan, Grand Rapids, Michigan, United States

  • Columbia University Medical Center - Herbert Irving Pavilion, New York, New York, United States

  • Duke University Medical Center, Durham, North Carolina, United States

    Contact: Study coordinator (Carol A Wiggs) · cao13@duke.edu
    Contact: Principal Investigator (April Salama, MD)

  • University of Cincinnati Cancer Center, Cincinnati, Ohio, United States

    Study coordinator · 513-584-7698
    Contact: Principal Investigator (Trisha Wise-Draper, MD)

  • The Cleveland Clinic Foundation, Cleveland, Ohio, United States

  • Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Marlana Orloff, MD) · marlana.orloff@jefferson.edu
    Contact: Principal Investigator (Marlana Orloff, MD)

  • The Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee, United States

    askSARAH · 844-482-4812
    Contact: Principal Investigator (Meredith McKean, MD)

  • The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Jordi Ahnert, MD) · JRodon@mdanderson.org
    Contact: Principal Investigator (Jordi Rodon Ahnert, MD)

  • Westmead Hospital, Sydney, New South Wales, Australia

  • Queensland, Woolloongabba, Australia

  • Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Study leads

  • George Cole Jr., MD

    Study Director

    gcole@ideayabio.com

View source on ClinicalTrials.gov(opens in a new tab)